Edwards lifesciences reports first quarter results

Irvine, calif.--(business wire)--edwards lifesciences (nyse: ew) today reported financial results for the quarter ended mar. 31, 2025. recent highlights q1 sales grew 6.2% to $1.41 billion, or 7.9% adjusted1 q1 tavr sales grew 3.8%; constant currency1 sales grew 5.4%, better than expected q1 tmtt sales grew 58% to $115 million with meaningful contribution to edwards' growth q1 eps of $0.622; adjusted1 eps of $0.64 sapien m3 ce mark approval uniquely positions edwards with a comprehensive tmtt p.
EW Ratings Summary
EW Quant Ranking